{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-039608","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.929602+00:00","generated_at":"2026-06-17T08:20:36.006931+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"P3 Health Partners Q4 2022 net loss $532.3M on $463.5M goodwill impairment; revenue up 40%","bullets":["Q4 capitated revenue $254.0M (+40% YoY); net loss $532.3M vs $118.2M loss, primarily due to $463.5M goodwill impairment.","Adjusted EBITDA loss $40.1M vs $35.6M; Adjusted EBITDA PMPM loss improved to $133 from $177 in Q4 2021.","Full-year 2022 network contribution improved 65% vs 2021; company affirms 2023 guidance, expects Adjusted EBITDA positive in early 2024.","Introduced year-end medical margin guidance as new non-GAAP metric."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-039608","json":"https://secwatch.observer/filing/0001104659-23-039608.json","markdown":"https://secwatch.observer/filing/0001104659-23-039608.md","text":"https://secwatch.observer/filing/0001104659-23-039608.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/0001104659-23-039608-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/tm2311097d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T08:20:36.006931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"253157f23ca8b8e490c921ee2608dc00da598264","claim":"P3 Health Partners Inc. updated its the fourth quarter and full year ended December 31, 2022 guidance (reaffirmed).","evidence_excerpt":"On March 31, 2023, P3 Health Partners Inc. (the “Company” or “P3”) announced its financial results for the three months and full year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923039608/0001104659-23-039608-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}